Entry - #615834 - INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 26; MRD26 - OMIM
# 615834

INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 26; MRD26


Alternative titles; symbols

MENTAL RETARDATION, AUTOSOMAL DOMINANT 26


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
7q11.22 Intellectual developmental disorder, autosomal dominant 26 615834 AD 3 AUTS2 607270
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
GROWTH
Height
- Short stature
Weight
- Low birth weight
HEAD & NECK
Head
- Microcephaly
- Brachycephaly
Face
- Short philtrum
Ears
- Low-set ears
Eyes
- Thick eyebrows
- High-arched eyebrows
- Downslanting palpebral fissures
- Short palpebral fissures
- Ptosis
- Strabismus
- Hypertelorism
Nose
- Deep nasal bridge
- Prominent nasal tip
- Broad nasal base
Mouth
- Narrow mouth (in some patients)
- Wide mouth (in some patients)
- Thick lips (in some patients)
ABDOMEN
Gastrointestinal
- Feeding difficulties
SKELETAL
- Joint contractures (in some patients)
Spine
- Kyphosis
- Scoliosis
Hands
- Shallow palmar creases
Feet
- Tight heel cords
- Arched feet
- Foot misalignment
NEUROLOGIC
Central Nervous System
- Delayed psychomotor development
- Intellectual disability
- Learning difficulties
- Speech delay
- Hypertonia (in some patients)
- Stiff movements (in some patients)
Behavioral Psychiatric Manifestations
- Autistic features
MISCELLANEOUS
- Variable features
- Dysmorphic features may be subtle
MOLECULAR BASIS
- Caused by mutation in the activator of transcription and developmental regulator gene (AUTS2, 607270.0001)
Intellectual developmental disorder, autosomal dominant - PS156200 - 67 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.11 Coffin-Siris syndrome 2 AD 3 614607 ARID1A 603024
1q21.3 White-Sutton syndrome AD 3 616364 POGZ 614787
1q21.3 GAND syndrome AD 3 615074 GATAD2B 614998
1q22 Intellectual developmental disorder, autosomal dominant 52 AD 3 617796 ASH1L 607999
1q25.3 Intellectual developmental disorder, autosomal dominant 75 AD 3 620988 DHX9 603115
1q44 Intellectual developmental disorder, autosomal dominant 22 AD 3 612337 ZBTB18 608433
2p25.3 Intellectual developmental disorder, autosomal dominant 39 AD 3 616521 MYT1L 613084
2q11.2 ?Intellectual developmental disorder, autosomal dominant 69 AD 3 617863 LMAN2L 609552
2q23.1 Intellectual developmental disorder, autosomal dominant 1 AD 3 156200 MBD5 611472
3p25.3 Intellectual developmental disorder, autosomal dominant 23 AD 3 615761 SETD5 615743
3p21.31 Intellectual developmental disorder, autosomal dominant 70 AD 3 620157 SETD2 612778
3q22.3 Intellectual developmental disorder, autosomal dominant 47 AD 3 617635 STAG1 604358
3q26.32 Intellectual developmental disorder, autosomal dominant 41 AD 3 616944 TBL1XR1 608628
3q27.1 Intellectual developmental disorder 60 with seizures AD 3 618587 AP2M1 601024
4q31.1 Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities AD 3 617787 NAA15 608000
5p15.2 Intellectual developmental disorder, autosomal dominant 63, with macrocephaly AD 3 618825 TRIO 601893
5p15.2 Intellectual developmental disorder, autosomal dominant 44, with microcephaly AD 3 617061 TRIO 601893
5q13.3 Neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic facies AD 3 616351 CERT1 604677
5q32 Intellectual developmental disorder, autosomal dominant 53 AD 3 617798 CAMK2A 114078
5q33.2 Intellectual developmental disorder, autosomal dominant 67 AD 3 619927 GRIA1 138248
6p21.32 Intellectual developmental disorder, autosomal dominant 5 AD 3 612621 SYNGAP1 603384
6q13 Intellectual developmental disorder, autosomal dominant 46 AD 3 617601 KCNQ5 607357
6q14.3 Intellectual developmental disorder, autosomal dominant 64 AD 3 619188 ZNF292 616213
6q22.1 Intellectual developmental disorder, autosomal dominant 55, with seizures AD 3 617831 NUS1 610463
6q24.2 Intellectual developmental disorder, autosomal dominant 43 AD 3 616977 HIVEP2 143054
6q25.3 Coffin-Siris syndrome 1 AD 3 135900 ARID1B 614556
7p22.1 Intellectual developmental disorder, autosomal dominant 48 AD 3 617751 RAC1 602048
7p13 Intellectual developmental disorder, autosomal dominant 54 AD 3 617799 CAMK2B 607707
7q11.22 Intellectual developmental disorder, autosomal dominant 26 AD 3 615834 AUTS2 607270
7q36.2 Intellectual developmental disorder, autosomal dominant 33 AD 3 616311 DPP6 126141
9p24 Intellectual developmental disorder, autosomal dominant 2 AD 4 614113 MRD2 614113
9q34.11 Intellectual developmental disorder, autosomal dominant 58 AD 3 618106 SET 600960
9q34.3 Kleefstra syndrome 1 AD 3 610253 EHMT1 607001
10p15.3 Intellectual developmental disorder, autosomal dominant 30 AD 3 616083 ZMYND11 608668
10q22.2 Intellectual developmental disorder, autosomal dominant 59 AD 3 618522 CAMK2G 602123
11p15.5 Vulto-van Silfout-de Vries syndrome AD 3 615828 DEAF1 602635
11q13.1 Coffin-Siris syndrome 7 AD 3 618027 DPF2 601671
11q13.1-q13.2 Schuurs-Hoeijmakers syndrome AD 3 615009 PACS1 607492
11q13.2 Intellectual developmental disorder, autosomal dominant 51 AD 3 617788 KMT5B 610881
11q24.2 Intellectual developmental disorder, autosomal dominant 4 AD 2 612581 MRD4 612581
12p13.1 Intellectual developmental disorder, autosomal dominant 6, with or without seizures AD 3 613970 GRIN2B 138252
12q12 Coffin-Siris syndrome 6 AD 3 617808 ARID2 609539
12q13.12 Intellectual developmental disorder, autosomal dominant, FRA12A type AD 3 136630 DIP2B 611379
12q13.2 Coffin-Siris syndrome 8 AD 3 618362 SMARCC2 601734
12q21.33 Intellectual developmental disorder, autosomal dominant 66 AD 3 619910 ATP2B1 108731
14q11.2 Intellectual developmental disorder, autosomal dominant 74 AD 3 620688 HNRNPC 164020
15q21.3 Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities AD 3 620330 RFX7 612660
16p13.3 Intellectual developmental disorder, autosomal dominant 72 AD 3 620439 SRRM2 606032
16q22.1 Intellectual developmental disorder, autosomal dominant 21 AD 3 615502 CTCF 604167
16q24.3 Intellectual developmental disorder, autosomal dominant 3 AD 3 612580 CDH15 114019
17p13.1 Intellectual developmental disorder, autosomal dominant 62 AD 3 618793 DLG4 602887
17q21.2 Coffin-Siris syndrome 5 AD 3 616938 SMARCE1 603111
17q21.31 Koolen-De Vries syndrome AD 3 610443 KANSL1 612452
17q23.1 Intellectual developmental disorder, autosomal dominant 56 AD 3 617854 CLTC 118955
17q23.2 Intellectual developmental disorder, autosomal dominant 61 AD 3 618009 MED13 603808
17q23.2 Intellectual developmental disorder, autosomal dominant 57 AD 3 618050 TLK2 608439
18q12.3 Intellectual developmental disorder, autosomal dominant 29 AD 3 616078 SETBP1 611060
19p13.3 Intellectual developmental disorder, autosomal dominant 65 AD 3 619320 KDM4B 609765
19p13.2 Coffin-Siris syndrome 4 AD 3 614609 SMARCA4 603254
19q13.12 Intellectual developmental disorder, autosomal dominant 68 AD 3 619934 KMT2B 606834
19q13.2 Intellectual developmental disorder, autosomal dominant 45 AD 3 617600 CIC 612082
20q11.23 ?Intellectual developmental disorder, autosomal dominant 11 AD 3 614257 EPB41L1 602879
20q13.33 Intellectual developmental disorder, autosomal dominant 73 AD 3 620450 TAF4 601796
20q13.33 Intellectual developmental disorder, autosomal dominant 38 AD 3 616393 EEF1A2 602959
21q22.13 Intellectual developmental disorder, autosomal dominant 7 AD 3 614104 DYRK1A 600855
22q11.23 Coffin-Siris syndrome 3 AD 3 614608 SMARCB1 601607
22q12.3 ?Intellectual developmental disorder, autosomal dominant 10 AD 3 614256 CACNG2 602911

TEXT

A number sign (#) is used with this entry because of evidence that autosomal dominant intellectual developmental disorder-26 (MRD26) is caused by heterozygous intragenic copy number variation in the KIAA0442 gene (AUTS2; 607270) on chromosome 7q11.


Clinical Features

Beunders et al. (2013) compared 17 well-characterized individuals with exonic deletions in the AUTS2 gene and found a variable syndromic phenotype, including impaired intellectual development, autism, short stature, microcephaly, cerebral palsy, and facial dysmorphisms. Beunders et al. (2013) found that all 17 probands for whom clinical data were available had impaired intellectual development and/or developmental delay; this had been the reason for diagnostic testing. One of the parents carrying an AUTS2 deletion had learning difficulties, 1 had mildly impaired intellectual development, and 1 had normal intelligence. Seven of the 17 probands were diagnosed with autism spectrum disorder or showed autistic behavior. Among the complete cohort of 21 individuals consisting of 17 probands and 4 family members carrying the AUTS2 deletion, 13 females and 8 males ranging in age from 11 months to 32 years at the time of examination, Beunders et al. (2013) observed low birthweight in 41% (7/17), short stature in 60% (12/20), microcephaly in 70% (14/20), and feeding difficulties in 48% (10/21). Only 14% (3/21) manifested hyperactivity disorder and/or ADHD. Thirty-eight percent (8/21) were hypotonic, 27% (3/11) had a structural brain anomaly, and 43% (9/21) had cerebral palsy and/or spasticity. Dysmorphic features noted by Beunders et al. (2013) included hypertelorism, ptosis, short and/or upturned philtrum, short palpebral fissures, prominent nasal tip, and narrow mouth. Skeletal abnormalities included kyphosis and/or scoliosis, arthrogryposis and/or shallow palmar creases, and tight heel cords. Beunders et al. (2013) developed an AUTS2 syndrome severity score. Cases and family members with 5-prime in-frame deletions scored significantly lower than did cases and family members with deletions of downstream exons, whole-gene deletions, or exon 1 through 4 deletions, including the initiation codon. This difference was significant, regardless of the inclusion or exclusion of affected family members, prompting further analysis of the 3-prime gene region of AUTS2.

Nagamani et al. (2013) reported 4 patients with copy number variations (CNVs) ranging in size from 133 to 319 kb that disrupted AUTS2. Two patients were sibs who inherited an identical 179-kb duplication of exon 5 from their mother. The other 2 patients had different intragenic deletions that involved exons 6 through 14. All patients had developmental delay. Both of the patients with the duplication had autism spectrum disorder. One had microcephaly, while the other was normocephalic; the normocephalic patient had seizures. The mother of these patients had microcephaly and mildly impaired intellectual development. One deletion patient had macrocephaly, dysmorphic facial features, failure to thrive, scoliosis, and atrial septal defect; brain MRI was normal. Her 133-kb deletion arose de novo. The second deletion patient had a head circumference in the 11th percentile at 3 years of age. She had no features of autism or seizures, and brain MRI was normal. Her deletion, which was 319 kb, encompassed that of the other patient.

Beunders et al. (2015) reported 2 unrelated males in their twenties with MRD26. Both patients had delayed psychomotor development with impaired intellectual development, an autism spectrum disorder, feeding difficulties after birth, mild distal joint contractures, and mild dysmorphic features, including ptosis, prominent nasal tip, deep nasal bridge, and short or upturned philtrum. One patient had severely delayed speech and foot misalignment requiring surgery. The other also had short stature, highly arched eyebrows, short palpebral fissures, strabismus, low-set ears, microretrognathia, highly arched feet, and stiff movements with mild peripheral hypertonia. The clinical features, although slightly variable, were consistent with those reported previously in patients with MRD26.

Beunders et al. (2016) reported 13 patients, including 6 adults, with an intellectual developmental disorder caused by mutation in the AUTS2 gene. Three of the patients had previously been reported and were reevaluated. All patients had developmental delay and borderline to severely impaired intellectual development with poor speech. Most had microcephaly and feeding difficulties early in life due to hypotonia. Congenital malformations were rare, but mild heart defects, contractures, and genital malformations occurred occasionally. Motor development was slightly delayed, and many had hyperreflexia or hypertonia. Only 2 had seizures. Most individuals tended to have friendly, outgoing social interactions; some features of autism were often observed, but none were diagnosed with classic autism. Patients with a small in-frame 5-prime deletion, which was often inherited, had a milder phenotype compared to those with haploinsufficiency of the full-length AUTS2 transcript, which occurred de novo.


Molecular Genetics

By combining the results of diagnostic testing of 49,684 individuals, Beunders et al. (2013) identified 24 microdeletions that affected at least 1 exon of AUTS2, as well as 1 translocation and 1 inversion each with a breakpoint within the AUTS2 locus. The authors then analyzed 16,784 controls from 12 cohorts by using arrays with high-density coverage of the AUTS2 locus. Although 9 deletions were found, none of them disrupted an AUTS2 exon. The difference between exonic deletions in the cases (24 of 49,651) and those in controls (0 of 16,784) was highly significant (p = 0.00092), suggesting that exonic disruptions of AUTS2 give rise to a highly penetrant phenotype in humans. Dysmorphic features were more pronounced in persons with 3-prime AUTS2 deletions. This part of the gene encodes a C-terminal isoform (with an alternative transcription start site) expressed in the human brain. Consistent with their genetic data, Beunders et al. (2013) found that suppression of auts2 in zebrafish embryos caused microcephaly that could be rescued by either the full-length or the C-terminal isoform of AUTS2.

In 2 unrelated men with MRD26, Beunders et al. (2015) identified 2 de novo heterozygous small deletions in the AUTS2 gene (607270.0003 and 607270.0004). Functional studies of the variants were not performed, but both were predicted to result in haploinsufficiency. The deletions were found by exome sequencing or array analysis.


REFERENCES

  1. Beunders, G., de Munnik, S. A., Van der Aa, N., Ceulemans, B., Voorhoeve, E., Groffen, A. J., Nillesen, W. M., Meijers-Heijboer, E. J., Kooy, R. F., Yntema, H. G., Sistermans, E. A. Two male adults with pathogenic AUTS2 variants, including a two-base pair deletion, further delineate the AUTS2 syndrome. Europ. J. Hum. Genet. 23: 803-807, 2015. [PubMed: 25205402, images, related citations] [Full Text]

  2. Beunders, G., van de Kamp, J., Vasudevan, P., Morton, J., Smets, K., Kleefstra, T., de Munnik, S. A., Schuus-Hoeijmakers, J., Ceulemans, B., Zollino, M., Hoffjan, S., Wieczorek, S., and 12 others. A detailed clinical analysis of 13 patients with AUTS2 syndrome further delineates the phenotypic spectrum and underscores the behavioural phenotype. J. Med. Genet. 53: 523-532, 2016. [PubMed: 27075013, related citations] [Full Text]

  3. Beunders, G., Voorhoeve, E., Golzio, C., Pardo, L. M., Rosenfeld, J. A., Talkowski, M. E., Simonic, I., Lionel, A. C., Vergult, S., Pyatt, R. E., van de Kamp, J., Nieuwint, A., and 51 others. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus. Am. J. Hum. Genet. 92: 210-220, 2013. [PubMed: 23332918, images, related citations] [Full Text]

  4. Nagamani, S. C. S., Erez, A., Ben-Zeev, B., Frydman, M., Winter, S., Zeller, R., El-Khechen, D., Escobar, L., Stankiewicz, P., Patel, A., Cheung, S. W. Detection of copy-number variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders. Europ. J. Hum. Genet. 21: 343-346, 2013. [PubMed: 22872102, related citations] [Full Text]


Cassandra L. Kniffin - updated : 12/20/2016
Cassandra L. Kniffin - updated : 1/13/2016
Creation Date:
Ada Hamosh : 6/4/2014
carol : 11/15/2024
alopez : 04/06/2022
carol : 12/21/2016
ckniffin : 12/20/2016
carol : 01/15/2016
ckniffin : 1/13/2016
alopez : 6/6/2014

# 615834

INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 26; MRD26


Alternative titles; symbols

MENTAL RETARDATION, AUTOSOMAL DOMINANT 26


ORPHA: 352490;   DO: 0070056;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
7q11.22 Intellectual developmental disorder, autosomal dominant 26 615834 Autosomal dominant 3 AUTS2 607270

TEXT

A number sign (#) is used with this entry because of evidence that autosomal dominant intellectual developmental disorder-26 (MRD26) is caused by heterozygous intragenic copy number variation in the KIAA0442 gene (AUTS2; 607270) on chromosome 7q11.


Clinical Features

Beunders et al. (2013) compared 17 well-characterized individuals with exonic deletions in the AUTS2 gene and found a variable syndromic phenotype, including impaired intellectual development, autism, short stature, microcephaly, cerebral palsy, and facial dysmorphisms. Beunders et al. (2013) found that all 17 probands for whom clinical data were available had impaired intellectual development and/or developmental delay; this had been the reason for diagnostic testing. One of the parents carrying an AUTS2 deletion had learning difficulties, 1 had mildly impaired intellectual development, and 1 had normal intelligence. Seven of the 17 probands were diagnosed with autism spectrum disorder or showed autistic behavior. Among the complete cohort of 21 individuals consisting of 17 probands and 4 family members carrying the AUTS2 deletion, 13 females and 8 males ranging in age from 11 months to 32 years at the time of examination, Beunders et al. (2013) observed low birthweight in 41% (7/17), short stature in 60% (12/20), microcephaly in 70% (14/20), and feeding difficulties in 48% (10/21). Only 14% (3/21) manifested hyperactivity disorder and/or ADHD. Thirty-eight percent (8/21) were hypotonic, 27% (3/11) had a structural brain anomaly, and 43% (9/21) had cerebral palsy and/or spasticity. Dysmorphic features noted by Beunders et al. (2013) included hypertelorism, ptosis, short and/or upturned philtrum, short palpebral fissures, prominent nasal tip, and narrow mouth. Skeletal abnormalities included kyphosis and/or scoliosis, arthrogryposis and/or shallow palmar creases, and tight heel cords. Beunders et al. (2013) developed an AUTS2 syndrome severity score. Cases and family members with 5-prime in-frame deletions scored significantly lower than did cases and family members with deletions of downstream exons, whole-gene deletions, or exon 1 through 4 deletions, including the initiation codon. This difference was significant, regardless of the inclusion or exclusion of affected family members, prompting further analysis of the 3-prime gene region of AUTS2.

Nagamani et al. (2013) reported 4 patients with copy number variations (CNVs) ranging in size from 133 to 319 kb that disrupted AUTS2. Two patients were sibs who inherited an identical 179-kb duplication of exon 5 from their mother. The other 2 patients had different intragenic deletions that involved exons 6 through 14. All patients had developmental delay. Both of the patients with the duplication had autism spectrum disorder. One had microcephaly, while the other was normocephalic; the normocephalic patient had seizures. The mother of these patients had microcephaly and mildly impaired intellectual development. One deletion patient had macrocephaly, dysmorphic facial features, failure to thrive, scoliosis, and atrial septal defect; brain MRI was normal. Her 133-kb deletion arose de novo. The second deletion patient had a head circumference in the 11th percentile at 3 years of age. She had no features of autism or seizures, and brain MRI was normal. Her deletion, which was 319 kb, encompassed that of the other patient.

Beunders et al. (2015) reported 2 unrelated males in their twenties with MRD26. Both patients had delayed psychomotor development with impaired intellectual development, an autism spectrum disorder, feeding difficulties after birth, mild distal joint contractures, and mild dysmorphic features, including ptosis, prominent nasal tip, deep nasal bridge, and short or upturned philtrum. One patient had severely delayed speech and foot misalignment requiring surgery. The other also had short stature, highly arched eyebrows, short palpebral fissures, strabismus, low-set ears, microretrognathia, highly arched feet, and stiff movements with mild peripheral hypertonia. The clinical features, although slightly variable, were consistent with those reported previously in patients with MRD26.

Beunders et al. (2016) reported 13 patients, including 6 adults, with an intellectual developmental disorder caused by mutation in the AUTS2 gene. Three of the patients had previously been reported and were reevaluated. All patients had developmental delay and borderline to severely impaired intellectual development with poor speech. Most had microcephaly and feeding difficulties early in life due to hypotonia. Congenital malformations were rare, but mild heart defects, contractures, and genital malformations occurred occasionally. Motor development was slightly delayed, and many had hyperreflexia or hypertonia. Only 2 had seizures. Most individuals tended to have friendly, outgoing social interactions; some features of autism were often observed, but none were diagnosed with classic autism. Patients with a small in-frame 5-prime deletion, which was often inherited, had a milder phenotype compared to those with haploinsufficiency of the full-length AUTS2 transcript, which occurred de novo.


Molecular Genetics

By combining the results of diagnostic testing of 49,684 individuals, Beunders et al. (2013) identified 24 microdeletions that affected at least 1 exon of AUTS2, as well as 1 translocation and 1 inversion each with a breakpoint within the AUTS2 locus. The authors then analyzed 16,784 controls from 12 cohorts by using arrays with high-density coverage of the AUTS2 locus. Although 9 deletions were found, none of them disrupted an AUTS2 exon. The difference between exonic deletions in the cases (24 of 49,651) and those in controls (0 of 16,784) was highly significant (p = 0.00092), suggesting that exonic disruptions of AUTS2 give rise to a highly penetrant phenotype in humans. Dysmorphic features were more pronounced in persons with 3-prime AUTS2 deletions. This part of the gene encodes a C-terminal isoform (with an alternative transcription start site) expressed in the human brain. Consistent with their genetic data, Beunders et al. (2013) found that suppression of auts2 in zebrafish embryos caused microcephaly that could be rescued by either the full-length or the C-terminal isoform of AUTS2.

In 2 unrelated men with MRD26, Beunders et al. (2015) identified 2 de novo heterozygous small deletions in the AUTS2 gene (607270.0003 and 607270.0004). Functional studies of the variants were not performed, but both were predicted to result in haploinsufficiency. The deletions were found by exome sequencing or array analysis.


REFERENCES

  1. Beunders, G., de Munnik, S. A., Van der Aa, N., Ceulemans, B., Voorhoeve, E., Groffen, A. J., Nillesen, W. M., Meijers-Heijboer, E. J., Kooy, R. F., Yntema, H. G., Sistermans, E. A. Two male adults with pathogenic AUTS2 variants, including a two-base pair deletion, further delineate the AUTS2 syndrome. Europ. J. Hum. Genet. 23: 803-807, 2015. [PubMed: 25205402] [Full Text: https://doi.org/10.1038/ejhg.2014.173]

  2. Beunders, G., van de Kamp, J., Vasudevan, P., Morton, J., Smets, K., Kleefstra, T., de Munnik, S. A., Schuus-Hoeijmakers, J., Ceulemans, B., Zollino, M., Hoffjan, S., Wieczorek, S., and 12 others. A detailed clinical analysis of 13 patients with AUTS2 syndrome further delineates the phenotypic spectrum and underscores the behavioural phenotype. J. Med. Genet. 53: 523-532, 2016. [PubMed: 27075013] [Full Text: https://doi.org/10.1136/jmedgenet-2015-103601]

  3. Beunders, G., Voorhoeve, E., Golzio, C., Pardo, L. M., Rosenfeld, J. A., Talkowski, M. E., Simonic, I., Lionel, A. C., Vergult, S., Pyatt, R. E., van de Kamp, J., Nieuwint, A., and 51 others. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus. Am. J. Hum. Genet. 92: 210-220, 2013. [PubMed: 23332918] [Full Text: https://doi.org/10.1016/j.ajhg.2012.12.011]

  4. Nagamani, S. C. S., Erez, A., Ben-Zeev, B., Frydman, M., Winter, S., Zeller, R., El-Khechen, D., Escobar, L., Stankiewicz, P., Patel, A., Cheung, S. W. Detection of copy-number variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders. Europ. J. Hum. Genet. 21: 343-346, 2013. [PubMed: 22872102] [Full Text: https://doi.org/10.1038/ejhg.2012.157]


Contributors:
Cassandra L. Kniffin - updated : 12/20/2016
Cassandra L. Kniffin - updated : 1/13/2016

Creation Date:
Ada Hamosh : 6/4/2014

Edit History:
carol : 11/15/2024
alopez : 04/06/2022
carol : 12/21/2016
ckniffin : 12/20/2016
carol : 01/15/2016
ckniffin : 1/13/2016
alopez : 6/6/2014